• R-Biopharm AG
  • Contact
  • Media
  • Online Seminars
  • Events
Languages
  • Nederlands
  • Italiano
  • Français
  • Deutsch
  • Español
  • English
Subscribe
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Syndromic Testing
    • Tuberculosis
    • Virology
  • Indication
    • Allergies
    • Dermatophyte Infections
    • Gastrointestinal infections
    • Hospital aquired infections and drug resistance
    • Respiratory infections
    • Sexually transmitted infections
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Immunoblot
    • ELISA
    • Real-time PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop
A Division of the R-Biopharm Group
  • Start
  • Diagnostics
    • Allergology
    • Autoimmunity
    • Bacteriology
    • Gastroenterology
    • Human genetics
    • Mycology
    • Parasitology
    • Syndromic Testing
    • Tuberculosis
    • Virology
  • Indication
    • Allergies
    • Dermatophyte Infections
    • Gastrointestinal infections
    • Hospital aquired infections and drug resistance
    • Respiratory infections
    • Sexually transmitted infections
    • Therapeutic drug monitoring
    • Vector-borne infections
  • Technologies
    • Array
    • Immunoblot
    • ELISA
    • Real-time PCR
    • Rapid tests
    • Quality Assessment Products
    • MT-PCR
  • Systems
  • Product Finder
  • News
  • Shop

Sexually transmitted infections

Home » Indication » Sexually transmitted infections
Obligation to report of chlamydia trachomatis serotypes L1- L3

Obligation to report of chlamydia trachomatis serotypes L1- L3

Please note: The proof of chlamydia trachomatis serotypes L1- L3 is to be reported since September 2022 We would like to draw your attention to the crucial importance of differentiating between [...]

READ MORE
More efficient and flexible: RIDA®GENE real-time PCR kits in the new format

More efficient and flexible: RIDA®GENE real-time PCR kits in the new format

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.

READ MORE
Sexually transmitted infections: the silent epidemic

Sexually transmitted infections: the silent epidemic

Sexually transmitted infections/diseases (STIs or STDs) like syphilis, gonorrhea, and chlamydia are on the rise worldwide. But hardly anyone talks about it. To mark STD Awareness Month, we [...]

READ MORE
R-Biopharm AG & Bosch Healthcare Solutions partner to develop molecular diagnostics for automated all-in-one platform

R-Biopharm AG & Bosch Healthcare Solutions partner to develop molecular diagnostics for automated all-in-one platform

R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular [...]

READ MORE

Clinical Diagnostics

A division of R-Biopharm AG
Subscribe to our newsletter
Company information
  • R-Biopharm AG
  • An der Neuen BergstraĂźe 17
    64297 Darmstadt, Germany
  • +49 (0) 61 51 - 81 02-0
  • +49 (0) 61 51 - 81 02-40
  • info@r-biopharm.de
  • www.r-biopharm.com
Copyright All Rights Reserved ©
  • Imprint
  • Privacy policy
  • GTCs
  • GTCs (Purchase)

Start typing and press Enter to search